Get started
Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with Elite Pharmaceuticals, Inc.



Key stats


Market capitalization
‪265.82 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
9.3477
Basic EPS (TTM)
0.0528 USD
Net income (FY)
‪44.87 M‬ USD
Revenue (FY)
‪148.87 M‬ USD
Shares float
‪836.06 M‬
Beta (1Y)
−0.18

Employees


Employees (FY)
65
Change (1Y)
−3−4.41%
Revenue / Employee (1Y)
‪2.29 M‬ USD
Net income / Employee (1Y)
‪690.35 K‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO
Nasrat A. Hakim
Website
elitepharma.com
Headquarters
Northvale
Founded
1997
IPO date
Feb 20, 2014
ISIN
US28659T2006
CUSIP
28659T200
FIGI
BBG000DPZTK5
Identifiers
ISIN US28659T2006
Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the following segments: Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of ELTP is 0.2581 USD — it has increased by 4.59% in the past 24 hours. Watch Elite Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Elite Pharmaceuticals, Inc. stocks are traded under the ticker ELTP.
ELTP stock has risen by 4.12% compared to the previous week, the month change is a −10.03% fall, over the last year Elite Pharmaceuticals, Inc. has showed a −59.35% decrease.
ELTP reached its all-time high on Mar 7, 2000 with the price of 24.5000 USD, and its all-time low was 0.0230 USD and was reached on Dec 6, 2021. View more price dynamics on ELTP chart.
See other stocks reaching their highest and lowest prices.
ELTP stock is 6.08% volatile and has beta coefficient of −0.18. Track Elite Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elite Pharmaceuticals, Inc. there?
Today Elite Pharmaceuticals, Inc. has the market capitalization of ‪265.82 M‬, it has decreased by −4.73% over the last week.
Yes, you can track Elite Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ELTP net income for the last quarter is ‪5.91 M‬ USD, while the quarter before that showed ‪18.46 M‬ USD of net income which accounts for 0.00% change. Track more Elite Pharmaceuticals, Inc. financial stats to get the full picture.
No, ELTP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 26, 2026, the company has 65 employees. See our rating of the largest employees — is Elite Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Elite Pharmaceuticals, Inc. EBITDA is ‪37.79 M‬ USD, and current EBITDA margin is 34.92%. See more stats in Elite Pharmaceuticals, Inc. financial statements.
Like other stocks, ELTP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elite Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elite Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elite Pharmaceuticals, Inc. stock shows the sell signal. See more of Elite Pharmaceuticals, Inc. technicals for a more comprehensive analysis.